AXDX — Accelerate Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Accelerate Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	108	68.3	63.6	45.6	13.2
Net Total Accounts Receivable
Net Total Receivables	3.22	1.55	2.32	2.42	2.62
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	122	82	73.3	56	24.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.8	9.32	7.9	7.76	5.08
Other Long Term Assets
Total Assets	134	93.4	83	65	31.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.16	6.97	6.95	66.6	12
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	142	156	118	87.3	51.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-7.38	-62.8	-35.1	-22.3	-19.9
Total Liabilities & Shareholders' Equity	134	93.4	83	65	31.4
Total Common Shares Outstanding
Total Preferred Shares Outstanding